These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3579517)

  • 21. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
    Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
    Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of salicylates administered with metoprolol.
    Spahn H; Langguth P; Kirch W; Mutschler E; Ohnhaus EE
    Arzneimittelforschung; 1986 Nov; 36(11):1697-9. PubMed ID: 3814230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
    Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
    [No Abstract]   [Full Text] [Related]  

  • 24. Clearance-based oral drug interaction between verapamil and metoprolol and comparison with atenolol.
    McLean AJ; Knight R; Harrison PM; Harper RW
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1628-9. PubMed ID: 4003307
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
    Folgering HT; Borm JF; van Haaren RH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
    Kaila T; Iisalo E
    J Clin Pharmacol; 1993 Oct; 33(10):959-66. PubMed ID: 8227468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple and rapid analysis of atenolol and metoprolol in plasma using solid-phase extraction and high-performance liquid chromatography.
    Harrison PM; Tonkin AM; McLean AJ
    J Chromatogr; 1985 May; 339(2):429-33. PubMed ID: 4008584
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
    van Zwieten PA; Timmermans PB
    J Cardiovasc Pharmacol; 1979; 1(1):85-96. PubMed ID: 94385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
    Dayer P; Leemann T; Marmy A; Rosenthaler J
    Eur J Clin Pharmacol; 1985; 28(2):149-53. PubMed ID: 2859203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of metoprolol.
    Regårdh CG; Johnsson G
    Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
    Niemelä MJ; Airaksinen KE; Huikuri HV
    J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
    Tantucci C; Bruni B; Dottorini ML; Peccini F; Motolese M; Lecaillon JB; Sorbini CA; Grassi V
    Am Heart J; 1990 Aug; 120(2):467-72. PubMed ID: 2200257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food-induced reduction in bioavailability of atenolol.
    Melander A; Stenberg P; Liedholm H; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line double focusing of atenolol and metoprolol in human urine using capillary electrophoresis with the aid of β-cyclodextrin.
    Wan Q; Liu Y; Yang C; Liu L
    Anal Chim Acta; 2017 Jul; 978():61-67. PubMed ID: 28595728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
    Dimenäs E; Dahlöf C; Olofsson B; Wiklund I
    Br J Clin Pharmacol; 1989 Nov; 28(5):527-34. PubMed ID: 2574052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.